Northern Trust
CPXX

Northern Trust’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Northern Trust’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-350,881
Closed -$10.6M – 4274
2016
Q2 		$10.6M Buy
350,881
+317,633
+955% +$6.45M ﹤0.01% 1987
2016
Q1 		$366K Buy
33,248
+12,524
+60% +$41K ﹤0.01% 3538
2015
Q4 		$37K Hold
20,724
– – ﹤0.01% 4103
2015
Q3 		$35K Buy
+20,724
New +$46K ﹤0.01% 4135

Northern Trust's CPXX Position: Q3 2016 in Review

Northern Trust sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 350,881 shares — an estimated $10.6M sold.

Northern Trust first reported a position in CPXX in Q3 2015 and held it in 4 quarters. The position peaked at $10.6M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Northern Trust reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Northern Trust sold 350,881 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $10.6M.
  • Northern Trust first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 4 quarters.
  • Northern Trust's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $10.6M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Northern Trust's 13F filing for Q3 2016, filed 10 Nov 2016.